Orphan Therapeutics Accelerator In-Licenses Gene Therapy Program for OTC Deficiency
Orphan Therapeutics Accelerator in-licensed the investigational OTXL-101 program from UCL Ventures and Children's Medical Research Institute for ornithine transcarbamylase deficiency.